Bubs Australia Limited (ASX: BUB) has reaffirmed its FY25 revenue guidance of AU$102 million, as outlined in last quarterly statement. Based on this target, here are three potential scenarios for their share price (SP) by the end of 2025
Base Case: P/S of 1.8 (slight premium for cash flow positivity and U.S. growth). Market cap = AU$102M × 1.8 = AU$183.6M. Share price = AU$183.6M ÷ 892.7M = AU$0.21.
Bull Case: P/S of 2.2 (optimism for FDA approval in October 2025, H1 FY26 upside). Market cap = AU$102M × 2.2 = AU$224.4M. Share price = AU$224.4M ÷ 892.7M = AU$0.25.
Bear Case: P/S of 1.3 (disappointment on profit or China stagnation). Market cap = AU$102M × 1.3 = AU$132.6M. Share price = AU$132.6M ÷ 892.7M = AU$0.15.
BUB Price at posting:
13.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)